Mirtazapine in comorbid major depression and alcohol dependence: An open-label trial

Journal of Dual Diagnosis

Volumn 8, Issue 3, 2012, Pages 200-204

  Cornelius, Jack R ^a   Douaihy, Antoine B ^a   Clark, Duncan B ^a   Chung, Tammy ^a   Scott Wood, D ^b   Daley, Dennis ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

alcohol dependence; comorbid; major depression; mirtazapine

Indexed keywords

MIRTAZAPINE;

ADULT; ALCOHOLISM; ARTICLE; BECK DEPRESSION INVENTORY; BEDTIME DOSAGE; CLINICAL ARTICLE; COMORBIDITY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; SEDATION; SIDE EFFECT;

EID: 84865270024     PISSN: 15504263     EISSN: 15504271     Source Type: Journal    
DOI: 10.1080/15504263.2012.696527     Document Type: Article

References (15)

1. Altintoprak, A. E., Zorlu, N., Coskunol, H., Akdeniz, F., & Kitapcioglu, G. (2008). Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: A randomized, double-blind study. Human Psychopharmacology, 23(4), 313-319. doi:10.1002/hup.935 (Pubitemid 351982668)
2. Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561-571. doi:10.1001/archpsyc.1961.01710120031004
3. Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (2008). Mood disorders measures. In A. John Rush Jr., Michael B. First, & Deborah Blacker, (Eds.), (Handbook of psychiatric measures, second edition (pp. 504-506). Washington, DC: American Psychiatric Publishing, Inc.
4. Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R. . . . Barbui, C. (2009). Comparative efficacy and acceptability of 12 new-generation antidepressants: A multiple-treatments metaanalysis. Lancet, 373, 746-758. doi:10.1016/S0140-6736(09)60046-5
5. Cornelius, J. R., Bukstein, O. G., Wood, D. S., Kirisci, L. Douaihy, A. B., & Clark, D. B. (2009). Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder. Addictive Behaviors, 34, 905-909. doi:10.1016/j.addbeh.2009.03.008
6. Lovieno, N., Tedeschini, E., Bentley, K. H., Evins, A. E., & Papakostas, G. I. (2011). Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: A meta-analysis of placebo-controlled randomized trials. Journal of Clinical Psychiatry, 72, 1144-1151. doi:10.4088/JCP.10m06217
7. Miller, W. R., Zweben, A., DiClemente, C. C., & Rychtarik, R. G. (1992). Motivational Enhancement Therapy manual. Project MATCHMonograph Series, Volume 2. Washington, DC: National Institute on Alcohol Abuse and Alcoholism.
8. Norusis, M. J. (1992). Norusis Statistical Package for the social sciences. New York, NY: McGraw-Hill.
9. Nunes, E. V., & Levin, F. B. (2004). Treatment of depression in patients with alcohol or other drug dependence. A meta-analysis. JAMA: Journal of the American Medical Association, 291, 1887-1896. doi:10.1001/jama.291.15. 1887 (Pubitemid 38509503)
10. Salloum, I. M., & Jones, Y. O. (2008). Efficacy of pharmacotherapy for comorbid major depression and substance use disorders: A review. Current Psychiatry Reviews, 4(1), 14-27. doi:10.2174/157340008783743785 (Pubitemid 351513494)
11. Sheehan, D. V., Lecrubier, Y., Sheehan, H., Amorim, P., Janars, J., Weiller, E., . . . Dunbar, G. C. (1998). The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59(s20), 22-33. (Pubitemid 29001829)
12. Sheehan, D. V., Lecrubier, Y., Sheehan, H., Amorim, P., Janars, J., Weiller, E., . . . Dunbar, G. C. (2008). Diagnostic measures for adults. In A. John Rush Jr., Michael B. First,&Deborah Blacker (Eds.), Handbook of psychiatric measures, second edition (pp. 48-51). Washington, DC: American Psychiatric Publishing, Inc.
13. Sobell, L. D., Sobell, M. B., Leo, G. I., & Cancilla, A. (1988). Reliability of a timeline method: Assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. British Journal of Addiction, 83, 393-402. dx.doi.org/10.1111/j.1360-0443.1988. tb00485.x
14. Watanabe, N., Omori, I. M., Nakagawa, A., Cipriani, A., Barbui, C., McGuire, H., . . . Furukawa, T. A. (2008). Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: Systematic review and meta-analysis. Journal of Clinical Psychiatry, 69(9), 1404-1415. doi:10.4088/JCP.v69n0908
15. Yoon, S. J., Pae, C. U., Kim, D. J., Namkoong, K., Lee, E., Oh, D. Y., . . . Lee, C. T. (2006). Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: A multicentre, open label study. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 30(7), 1196-1201. doi:10.1016/j.pnpbp.2006.02.018